An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene

Journal of Immunology

Volumn 160, Issue 3, 1998, Pages 1268-1278

  Makar, Karen W ^a   Pham, Christine T N ^b   Dehoff, Marlin H ^a   O'Connor, Siobhan M ^b   Jacobi, Susan M ^b   Holers, V Michael ^a,c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3D RECEPTOR; DEOXYRIBONUCLEASE I;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL NUCLEUS MATRIX; CHROMATIN; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INTRON; LYMPHOID TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAJI CELL; RECEPTOR GENE; REPORTER GENE; SILENCER GENE; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; BINDING SITES; CELL DIFFERENTIATION; DEOXYRIBONUCLEASE I; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTRONS; MALE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; RECEPTORS, COMPLEMENT 3D; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0031914423     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Cooper, N. R., M. D. Moore, and G. R. Nemerow. 1988. Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment. Annu. Rev. Immunol. 6:85.
2. Hourcade, D., V. M. Holers, and J. P. Atkinson. 1989. The regulators of complement activation (RCA) gene cluster. Adv. Immunol. 45:381.
3. Iida, K., L. Nadler, and V. Nussenzweig. 1983. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody. J. Exp. Med. 158:1021.
4. r membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc. Natl. Acad. Sci. USA 81:881.
5. Fingeroth, J. D., J. J. Weis, T. F. Tedder, J. L. Strominger, P. A. Biro, and D. T. Fearon. 1984. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. USA 81:4510.
6. Nemerow, G. R., R. Wolfert, M. E. McNaughton, and N. R. Cooper. 1985. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J. Virol. 55:347.
7. Aubry, J.-P., S. Pochon, J.-F. Gauchat, A. Nueda-Marin, V. M. Holers, P. Graber, C. Siegfried, and J.-Y. Bonnefoy. 1994. CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. J. Immunol. 152:5806.
8. Delcayre, A. X., F. Salas, S. Mathur, K. Kovats, M. Lotz, and W. Lernhardt. 1991. Epstein-Barr virus/complement C3d receptor is an interferon-α receptor. EMBO J. 10:919.
9. Tedder, T. F., L. T. Clement, and M. D. Cooper. 1984. Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J. Immunol. 133:678.
10. Campana, D., G. Janossy, M. Bofill, L. K. Trejdosiewicz, D. Ma, V. Hoffbrand, D. Y. Mason, A. M. Lebacq, and H. K. Forster. 1985. Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. J. Immunol. 134:1524.
11. Hartley, S. B., M. P. Cooke, D. A. Fulcher, A. W. Harris, S. Cory, A. Basten, and C. C. Goodnow. 1993. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 72:325.
12. Loffert, D., S. Schaal, A. Ehlich, R. R. Hardy, Y.-R. Zou, W. Muller, and K. Rajewsky. 1994. Early B-cell development in the mouse: insights from mutations introduced by gene targeting. Immunol. Rev. 137:135.
13. Tiegs, S. L., D. M. Russell, and D. Nemazec. 1993. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177:1009.
14. Reynes, M., J. P. Aubert, J. H. M. Cohen, J. Audouin, V. Tricottet, J. Diebold, and M. D. Kazatchkine. 1985. Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J. Immunol. 135:2687.
15. Tsoukas, C. D., and J. D. Lambris. 1988. Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies. Eur. J. Immunol. 18:1299.
16. Fischer, E., C. Delibrias, and M. D. Kazatchkine. 1991. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J. Immunol. 146:865.
17. Levy, E., J. Ambrus, L. Kahl, H. Molina, K. Tung, and V. M. Holers. 1992. T lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 90:235.
18. Birkenbach, M., X. Tong, L. E. Bradbury, T. F. Tedder, and E. Kieff. 1992. Characterization of an Epstein-Barr virus receptor on human epithelial cells. J. Exp. Med. 176:1405.
19. Uckun, F. M. 1990. Regulation of human B-cell ontogeny. Blood 76:1908.
20. Takahashi, K., Y. Kozono, T. J. Waldschmidt, D. Berthiaume, R. J. Quigg, A. Baron, and V. M. Holers. 1997. Mouse complement receptors type 1 (CR1; CD35) and type 2 (CR2: CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. J. Immunol. 159:1557.
21. Molina, H., T. Kinoshita, K. Inoue, J.-C. Carel, and V. M. Holers. 1990. A molecular and immunochemical characterization of mouse CR2: evidence for a single gene model of mouse complement receptors 1 and 2. J. Immunol. 145: 2974.
22. Kurtz, C. B., M. S. Paul, M. Aegerter, J. J. Weis, and J. H. Weis. 1989. Murine complement receptor gene family. II. Identification and characterization of the murine homolog (Cr2) to human CR2 and its molecular linkage to Crry. J. Immunol. 143:2058.
23. Pramoonjago, P., J. Takeda, Y. U. Kim, K. Inoue, and T. Kinoshita. 1993. Ligand specificities of mouse complement receptor type 1 (CR1) and 2 (CR2) purified from spleen cells. Int. Immunol. 5:337.
24. Molina, H., V. M. Holers, B. Li, Y. Fang, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, W. R. Karr, and D. D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93:3357.
25. Ahearn, J. M., M. B. Fischer, D. A. Croix, S. Georg, M. Ma, J. Xia, X. Zhou, R. G. Howard, T. L. Rothstein, and M. C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4:251.
26. Croix, A. D., J. M. Ahearn, A. M. Rosengard, S. Han, G. Kelsoe, M. Ma, and M. C. Carroll. 1996. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. Exp. Med. 183:1857.
27. Dempsey, P. W., M. E. Allison, S. Akkaraju, C. C. Goodnow, and D. T. Fearon. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271:348.
28. Carter, R. H., M. O. Spycher, Y. C. Ng, R. Hoffman, and D. T. Fearon. 1988. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141:457.
29. Bohnsack, J. F., and N. R. Cooper. 1988. CR2 ligands modulate human B cell activation. J. Immunol. 141:2569.
30. Luxembourg, A. T., and N. R. Cooper. 1994. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV. J. Immunol. 153:4448.
31. Matsumoto, A. K., J. Kopicky-Burd, R. H. Carter, D. A. Tuveson, T. F. Tedder, and D. T. Fearon. 1991. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J. Exp. Med. 173:55.
32. Carter, R. H., and D. T. Fearon. 1992. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105.
33. Aubry, J. P., S. Pochon, P. Graber, K. U. Jansen, and J. Y. Bonnefoy. 1992. CD21 is a ligand for CD23 and regulates IgE production. Nature 358:505.
34. Henchoz, S., J. F. Gauchat, J. P. Aubry, P. Graber, S. Pochon, and J. Y. Bonnefoy. 1994. Stimulation of human IgE production by a subset of anti-CD21 monoclonal antibodies: requirement of a co-signal to modulate epsilon transcripts. Immunology 81:285.
35. Kansas, G. S., and T. F. Tedder. 1991. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway. J. Immunol. 147:4094.
36. Roberts, M. L., A. T. Luxembourg, and N. R. Cooper. 1996. Epstein-Barr virus binding to CD21, the virus receptor, activates resting B cells via an intracellular pathway that is linked to B cell infection. J. Gen. Virol. 77:3077.
37. Kehrl, J. H., A. Riva, G. L. Wilson, and C. Thevenin. 1994. Molecular mechanisms regulating CD19, CD20 and CD22 gene expression. Immunol. Today 15: 432.
38. Kozmik, Z., S. Wang, P. Dorfler, B. Adams, and M. Busslinger. 1992. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell. Biol. 12:2662.
39. Thevenin, C., B. P. Lucas, E. J. Kozlow, and J. H. Kehrl. 1993. Cell type- and stage-specific expression of the CD20/B1 antigen correlates with the activity of a diverged octamer DNA motif present in its promoter. J. Biol. Chem. 268:5949.
40. Wilson, G. L., V. Najfeld, E. Kozlow, J. Menninger, D. Ward, and J. H. Kehrl. 1993. Genomic structure and chromosomal mapping of the human CD22 gene. J. Immunol. 150:5013.
41. Andersson, K. B., K. E. Draves, D. M. Magaletti, S. Fujioka, K. L. Holmes, C. Law, and E. A. Clark. 1996. Characterization of the expression and gene promoter of CD22 in murine B cells. Eur. J. Immunol. 26:3170.
42. Schubach, W. H., G. Horvath, C. LeVea, and J Tierney. 1997. Chromatin structure of the lymphocyte Fcε receptor gene (CD23): identification of an upstream transcriptional enhancer. J. Immunol. 158:2228.
43. Wang, F., C. D. Gregory, M. Rowe, A. B. Rickinson, D. Wang, M. Birkenbach, H. Kikutani, T. Kishimoto, and E. Kieff. 1987. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc. Natl. Acad. Sci. USA 84:3452.
44. Cordier-Bussat, M., M. Billaud, A. Calender, and G. M. Lenoir. 1993. Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context. Int. J. Cancer 53:153.
45. Hsieh, J.-D., and S. D. Hayward. 1995. Masking of the CBF1/RBPJκ transcriptional repression domain by Epstein-Barr virus EBNA2. Science 268:560.
46. Ling, P. D., J. J.-D. Hsieh, I. K. Ruf, D. R. Rawlins, and S. D. Hayward. 1994. EBNA-2 up-regulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. J. Virol. 68: 5375.
47. Henkel, T., P. D. Ling, S. D. Hayward, and M. G. Peterson. 1994. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein Jκ. Science 265:92.
48. Johannsen, E., E. Koh, G. Mosialos, X. Tong, E. Kieff, and S. R. Grossman. 1995. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by Jκ and PU.1. J. Virol. 69:253.
49. Tong, X., R. Drapkin, R. Yalamanchili, G. Mosialos, and E. Kieff. 1995. The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE. Mol. Cell. Biol. 15:4735.
50. McNearney, T. A., C. F. Ebenlichler, M. Totsch, and M. P. Dierich. 1993. Expression of complement receptor 2 (CR2) on HTLV-1-infected lymphocytes and transformed cell lines. Eur. J. Immunol. 23:1266.
51. Rayhel, E. J., M. H. Dehoff, and V. M. Holers. 1991. Characterization of the human complement receptor 2 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins. J. Immunol. 146:2021.
52. Yang, L., M. Behrens, and J. J. Weis. 1991. Identification of 5′-regions affecting the expression of the human CR2 gene. J. Immunol. 147:2404.
53. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294.
54. Fujisaku, A., J. B. Harley, M. B. Frank, B. A. Gruner, B. Frazier, and V. M. Holers. 1989. Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor. J. Biol. Chem. 264:2118.
55. Post, T. W., K. Liszewski, E. M. Adams, I. Tedja, E. A. Miller, and J. P. Atkinson. 1991. Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype. J. Exp. Med. 174:93.
56. Lublin, D. M., M. K. Liszewski, T. W. Post, M. A. Arce, M. M. LeBeau, M. B. Rebentisch, R. S. Lemons, T. Seya, and J. P. Atkinson. 1988. Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). J Exp. Med. 168:181.
57. Hanson, R. D., N. L. Connolly, D. Burnett, E. J. Campbell, R. M. Senior, and T. J. Ley. 1990. Developmental regulation of the human cathepsin G gene in myelomonocytic cells. J. Biol. Chem. 265:1524.
58. Hourcade, D., A. D. Garcia, T. W. Post, P. Taillon-Miller, V. M. Holers, L. M. Wagner, N. S. Bora, and J. P. Atkinson. 1992. Analysis of the human regulators of complement activation (RCA) gene cluster with yeast artificial chromosomes (YACs). Genomics 12:289.
59. Ulrich, M., and T. J. Ley. 1990. Function of normal and mutated -γ-globin gene promoters in electroporated K562 erythroleukemia cells. Blood 75:990.
60. Gutkind, J. S., D. C. Link, S. Katamine, P. Lacal, T. Miki, T. J. Ley, and K. C. Robbins. 1991. A novel c-fgr exon utilized in Epstein-Barr virus-infected B lymphocytes but not in normal monocytes. Mol. Cell. Biol. 11:1500.
61. Hanson, R. D., P. A. Hohn, N. C. Popescu, and T. J. Ley. 1990. A cluster of hematopoietic serine protease genes is found on the same chromosomal band as the human α/δ T-cell receptor locus. Proc. Nait Acad. Sci. USA 87:960.
62. Saragosti, S., G. Moyne, and M. Yaniv. 1980. Absence of nucleosomes in a fraction of SV40 chromatin between the origin of replication and the region coding for the late leader RNA. Cell 20:65.
63. McGuire, E. A., C. E. Rintoul, G. M. Sclar, and S. J. Korsmeyer. 1992. Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma. Mol. Cell. Biol. 12:4186.
64. Ghosh, P. K., V. B. Reddy, J. Swinscoe, P. Lebowitz, and S. M. Weissman. 1978. Heterogeneity and 5′-terminal structures of the late RNAs of simian virus 40. J. Mol. Biol. 126:813.
65. Paul, M. S., M. Aegerter, K. Cepek, M. D. Miller, and J. H. Weis. 1990. The murine complement receptor gene family. III. The genomic and transcriptional complexity of the Crry and Crry-ps genes. J. Immunol. 144:1988.
66. Li, B., C. Sallee, M. Dehoff, S. Foley, H. Molina, and V. M. Holers. 1993. Mouse Crry/p65: characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J. Immunol. 151:4295.
67. Korsmeyer, S. J., A. Arnold, A. Bakshi, J. V. Ravetch, U. Siebenlist, P. A. Hieter, S. O. Sharrow, T. W. LeBien, J. H. Kersey, D. G. Poplack, P. Leder, and T. A. Waldmann. 1983. Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J. Clin. Invest. 71:301.
68. Siminovitch, K. A., J. P. Jensen, A. L. Epstein, and S. J. Korsmeyer. 1986. Immunoglobulin gene rearrangements and expression in diffuse histiocytic lymphomas reveal cellular lineage, molecular defects, and sites of chromosomal translocation. Blood 67:391.
69. Ernst, P., and S. T. Smale. 1995. Combinatorial regulation of transcription I: general aspects of transcriptional control. Immunity 2:311.
70. Kinoshita, T., J. Takeda, K. Hong, H. Kozono, H. Sakai, and K. Inoue. 1988. Monoclonal antibodies to mouse complement receptor type 1 (CR1): their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J. Immunol. 140:3066.
71. Holguin, M. H., C. B. Kurtz, C. J. Parker, J. J. Weis, and J. H. Weis. 1990. Loss of human CR1 - and murine Crry-like exons in human CR2 transcripts due to CR2 gene mutations. J. Immunol. 145:1776.
72. Sawada, S., J. D. Scarborough, N. Killeen, and D. R. Littman. 1994. A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development. Cell 77:917.
73. Siu, G., A. L. Wurster, D. D. Duncan, T. M. Soliman, and S. M. Hedrick. 1994. A transcriptional silencer controls the developmental expression of the CD4 gene. EMBO J. 13:3570.
74. Duncan, D. D., M. Adlam, and G. Siu. 1996. Asymmetric redundancy in CD4 silencer function. Immunity 4:301.
75. Hu, H., B. K. Martin, J. J. Weis, and J. H. Weis. 1997. Expression of the murine CD21 gene is regulated by promoter and intronic sequences. J. Immunol. 158: 4758.
76. Forrester, W. C., C. van Genderson, T. Jenuwein, and R. Grosschedl. 1994. Dependence of enhancer-mediated transcription of the immunoglobulin M gene on nuclear matrix attachment regions. Science 265:1221.
77. Xu, M., R. E. Hammer, V. C. Blasquez, S. L. Jones, and W. T. Garrard. 1989. Immunoglobulin K gene expression after stable integration. J. Biol. Chem. 264: 21190.
78. Stanhope-Baker, P., M. K. Hudson, L. A. Shaffer, A. Constantinescu, and S. M. Schlissel. 1996. Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro. Cell 85:887.
79. Boulikas, T. 1993. Nature of DNA sequences at the attachment regions of genes to the nuclear matrix. J. Cell. Biochem. 52:14.
80. Sander, M., and T. Hsieh. 1985. Drosophila topoisomerase II double-strand DNA cleavage: analysis of DNA sequence homology at the cleavage site. Nucleic Acids Res. 13:1057.